Ahsan Rizwan

684 total citations
12 papers, 342 citations indexed

About

Ahsan Rizwan is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Ahsan Rizwan has authored 12 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Ahsan Rizwan's work include Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Ahsan Rizwan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Ahsan Rizwan collaborates with scholars based in Germany, United States and China. Ahsan Rizwan's co-authors include Gerhard Burckhardt, Wolfgang Krick, Sotiria Tavoulari, Lucy R. Forrest, Gary Rudnick, Hao Zheng, Tarek Meniawy, Wei Phin Tan, Nageshwar Budha and Sophia Frentzas and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Ahsan Rizwan

11 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ahsan Rizwan Germany	7	209	93	85	45	45	12	342
Habib Hasannejad Japan	6	213 1.0×	85 0.9×	120 1.4×	55 1.2×	37 0.8×	7	437
Kazushige Takahashi Japan	10	175 0.8×	110 1.2×	119 1.4×	17 0.4×	47 1.0×	26	400
Kristen K. Evans United States	14	290 1.4×	216 2.3×	132 1.6×	42 0.9×	57 1.3×	27	494
Eva Doleželová Czechia	16	137 0.7×	109 1.2×	69 0.8×	14 0.3×	35 0.8×	26	484
Jeffry C. Granados United States	11	135 0.6×	106 1.1×	61 0.7×	41 0.9×	51 1.1×	15	315
Hiroya Mizutamari Japan	11	412 2.0×	127 1.4×	176 2.1×	20 0.4×	63 1.4×	16	664
Michael Looby Switzerland	12	59 0.3×	43 0.5×	72 0.8×	34 0.8×	23 0.5×	23	432
Sumito Ito Japan	10	346 1.7×	96 1.0×	246 2.9×	10 0.2×	52 1.2×	14	504
Sarah Billington United States	10	312 1.5×	82 0.9×	173 2.0×	18 0.4×	29 0.6×	10	446

Countries citing papers authored by Ahsan Rizwan

Since Specialization

Citations

This map shows the geographic impact of Ahsan Rizwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahsan Rizwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahsan Rizwan more than expected).

Fields of papers citing papers by Ahsan Rizwan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahsan Rizwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahsan Rizwan. The network helps show where Ahsan Rizwan may publish in the future.

Co-authorship network of co-authors of Ahsan Rizwan

This figure shows the co-authorship network connecting the top 25 collaborators of Ahsan Rizwan. A scholar is included among the top collaborators of Ahsan Rizwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahsan Rizwan. Ahsan Rizwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Rizwan, Ahsan, Hugh Giovinazzo, Kun Wang, et al.. (2025). Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model‐Based Approach. Clinical and Translational Science. 18(5). e70223–e70223.

Frentzas, Sophia, Steven Kao, Hao Zheng, et al.. (2023). AdvanTIG-105: a phase I dose escalation study of the anti-TIGIT monoclonal antibody ociperlimab in combination with tislelizumab in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer. 11(10). e005829–e005829. 25 indexed citations

Shi, Yang, Han Yan, Zhirong Shen, et al.. (2022). 768 Peripheral pharmacodynamic (PD) effects of ociperlimab (OCI) in combination with tislelizumab (TIS) in patients with advanced solid tumors: AdvanTIG-105 Phase 1 dose-escalation study. Regular and Young Investigator Award Abstracts. A799–A799. 2 indexed citations

Demin, Oleg, et al.. (2022). Abstract 5421: Prediction of intratumoral TIGIT receptor occupancy after the treatment with anti-TIGIT antibodies. Cancer Research. 82(12_Supplement). 5421–5421. 1 indexed citations

Siefker‐Radtke, Arlene O., Mayer Fishman, Arjun Vasant Balar, et al.. (2019). NKTR-214 + nivolumab in first-line advanced/metastatic urothelial carcinoma (mUC): Updated results from PIVOT-02.. Journal of Clinical Oncology. 37(7_suppl). 388–388. 18 indexed citations

Vaena, Daniel A., Jorge Chaves, Nicholas J. Vogelzang, et al.. (2018). PROPEL: A phase 1/2 trial of NKTR-214 (CD122-biased agonist) combined with anti-PD-1 (pembrolizumab) or anti-PD-L1 (atezolizumab) in patients (pts) with advanced solid tumors.. Journal of Clinical Oncology. 36(15_suppl). TPS3115–TPS3115. 3 indexed citations

Rizwan, Ahsan. (2011). Use of a Mutilumen Catheter to Assess the Bioavailability of an Enteric- Coated High-Buffered Pancrelipase Formulation in Patients with Exocrine Pancreatic Insufficiency. Journal of Bioequivalence & Bioavailability. 3(2). 2 indexed citations

Tavoulari, Sotiria, Ahsan Rizwan, Lucy R. Forrest, & Gary Rudnick. (2010). Reconstructing a Chloride-binding Site in a Bacterial Neurotransmitter Transporter Homologue. Journal of Biological Chemistry. 286(4). 2834–2842. 28 indexed citations

Rizwan, Ahsan, Wolfgang Krick, & Gerhard Burckhardt. (2007). The Chloride Dependence of the Human Organic Anion Transporter 1 (hOAT1) Is Blunted by Mutation of a Single Amino Acid. Journal of Biological Chemistry. 282(18). 13402–13409. 35 indexed citations

10.

Rizwan, Ahsan & Gerhard Burckhardt. (2007). Organic Anion Transporters of the SLC22 Family: Biopharmaceutical, Physiological, and Pathological Roles. Pharmaceutical Research. 24(3). 450–470. 213 indexed citations

11.

Hagos, Yohannes, et al.. (2006). Functional roles of cationic amino acid residues in the sodium-dicarboxylate cotransporter 3 (NaDC-3) from winter flounder. American Journal of Physiology-Renal Physiology. 291(6). F1224–F1231. 7 indexed citations

12.

Rizwan, Ahsan, et al.. (2004). Effects of gabapentin and antidepressant drug combinations on convulsions and memory in mice.. PubMed. 55(6). 965–71. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact